Abstract

Introduction. Euroregions with the participation of constituent entities of the Russian Federation have been actively created since 1998 and still remain a popular form of developing cross-border cooperation with neighboring countries. Cooperation in the format of Euroregions has been aimed at solving the socio-economic problems of the border regions. However, each individual project of a Euroregion has its specific features. The purpose of this paper is to analyze the current state of cooperation in the format of Euroregions of the European and post-Soviet types, as well as the possibilities of extrapolating the experience of Euroregions with Russian participation. Materials and Methods. The available studies on Euroregions, as well as materials from the official website of the Ministry of Foreign Affairs of the Russian Federation and those of the Euroregions, were used as materials for this research. The comparative analysis as well as SWOT analysis made it possible to highlight the strengths and weaknesses of the European-type and post-Soviet-type models of Euroregions and formed the methodological basis of the study. Results. The author has analyzed all the main results of the activities of the Euroregions of the European and post-Soviet types. Conclusions regarding the strengths and weaknesses of each type of the Euroregions have been made. In order to consider the possibility of extrapolating the European experience in establishing Euroregions in the Eurasian space, the cases of two projects of Euroregions, ‘Our Common Home – Altai’ and ‘Transnistria’, have been studied. The conclusions were drawn regarding the interests of both the local authorities and the political elite of the federal center in the development of cross-border cooperation programs, which is an important factor in the successful functioning of the Euroregions with the participation of constituent entities of the Russian Federation. Discussion and Conclusion. Analysis of the current state of the Euroregions with Russian participation made it possible to conclude that the format of the Euroregion itself is an effective form of cross-border cooperation. Based on the analysis of the strengths and weaknesses of the Euroregions, recommendations have been produced on organizing cross-border cooperation in the format of Euroregions in the Eurasian space, the most advantageous area for Russia; this can be of practical importance for strengthening bilateral international relations.

Highlights

  • In the context of global competition between intellectual industries and building transnational structures that ensure socio-economic development, joining the world’s top 5 most innovative economies is possible only in case of increasing the science intensity of the business sector of the economy

  • Based on the results of the study conducted, the article gives an analysis of the industry average values of the costs of enterprises for research and development (R&D) in economically developed countries and outlines proposals for achieving a similar level of costs for such work in Russia

  • The practice of strategizing Russia’s regions makes it possible to single out the regional dimension as a self-sufficient subject of cognitive modeling

Read more

Summary

Introduction

Ensuring the safety of medicines is the basis for the existence and functioning of any pharmacovigilance system as a type of activity aimed at obtaining and processing information about the undesirable consequences of the use of medicines. Исследование особенностей функционирования систем фармаконадзора в странах – участницах международной программы мониторинга безопасности лекарственных средств позволило выделить несколько типов организации сбора информации о нежелательных реакциях лекарственных средств: централизованный, децентрализованный и смешанный. Такой тип организации системы фармаконадзора представлен, например, в США, где все контролирующие функции в сфере оборота лекарственных средств возложены на Управление по санитарному надзору за качеством пищевых продуктов и медикаментов (Food and Drug Administration, FDA), которое является одним из федеральных исполнительных департаментов Министерства здравоохранения и социальных служб США. Основой функционирования централизованной системы фармаконадзора в США является программа MedWatch, позволяющая специалистам здравоохранения, пациентам и потребителям предоставлять в FDA информацию о нежелательных реакциях, возникающих при применении рецептурных и безрецептурных лекарственных средств, особенностях применения биологических препаратов, специальных пищевых продуктов (например, детских питательных смесей), а также о медицинских приборах и косметологических средствах. The centralized type of organization of the pharmacovigilance system exemplified by the U.S Food and Drug Administration (FDA)

Рейтинг инновационных экономик – 2019
О Стратегии национальной безопасности Российской Федерации
Implementation of Scenario 4 in the Republic of Mordovia
Academia and Communities
Sources of information about the Republic of Crimea for respondents
11. International Media Image of Russia
MedWatch
13 Об утверждении Порядка осуществления фармаконадзора
Pharmacovigilance in Europe
22. Stimulated Reporting
Findings
Organizational Culture and the Implementation of Person Centered Care
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call